Benzinga | Aug 31, 2021 11:19AM EDT

Tiziana Life Sciences Sponsored Study Titled 'A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting

https://clinicaltrials.gov/ct2/show/NCT05028946